Olivier F. Bertrand

Rosiglitazone influences adipose tissue distribution without deleterious impact on heart rate variability in coronary heart disease patients with type 2 diabetes

J. Després, N. Alméras, O. Bertrand, 2016, Clinical Autonomic Research.